Episode
The Atom Bomb Speaks: Tracy Høeg on COVID, Myocarditis, and the FDA From the Inside
- Podcast
- The Doctor's Lounge
- Published
- Jun 10, 2026
- Duration seconds
- 4405
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-doctor-s-lounge-7442524/episodes/the-atom-bomb-speaks-tracy-h-eg-on-covid-myocarditis-and-the-fda-from-the-inside/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-doctor-s-lounge-7442524/the-atom-bomb-speaks-tracy-h-eg-on-covid-myocarditis-and-the-fda-from-the-inside.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode Summary Dr. Tracy Høeg — physician, epidemiologist, and former Acting Director of the FDA's Center for Drug Evaluation and Research — joins Drs. Koka and DiGiorgio for her first interview since being fired from the agency in May 2025. She traces her unusual path from ophthalmology dropout to professional ultramarathoner to one of the most consequential and contested researchers of the COVID era, walking through her school transmission studies, the myocarditis preprint that detonated on social media, and what she actually found when she got inside the FDA: career scientists who were sharp, collegial, and largely aligned with her — not the entrenched bureaucratic resistance she expected. She also gives the most detailed account yet of how her firing went down, why she refused to resign, and what she thinks it signals about pharmaceutical industry influence over the agency. Chapter Markers 00:00 Introduction and Tracy's bio 02:19 Origin story: French major, med school, ophthalmology dropout 07:42 Seven years in Denmark: PhD, clinical work, ultra marathon racing 10:55 Back to the US: PM&R, interventional spine, and the start of COVID research 13:43 Funding research outside the NIH pipeline 17:18 How government funding crowds out independent science 20:59 Evidence-based medicine, spine, and the N-of-one problem 25:35 The Wisconsin school transmission study 28:32 If masks were a drug, would they pass FDA approval? 30:04 Testifying before Congress three times 32:46 The myocarditis preprint: origins, backlash, and vindication 38:34 Post-vaccine myocarditis: what the data actually showed 43:01 Regulatory failure, COVID vaccine risk-benefit, and the pediatric question 45:09 How Europe and Scandinavia got it right earlier 47:58 Cancel culture in academia and the chill…